Ron Branning, chief executive officer and co-founder of GXP Quality Systems, is responsible for collaborating with the COO on the overall strategy for the company. He is the principal consultant for the transition from clinical to commercial (GMP, GDP) aspects of the consulting services and has primary responsibility for management oversight and governance of deliverables to clients. With more than 50 years’ experience in the bio/pharmaceutical industry, Ron brings a wealth of worldwide quality experience in devices, drugs, biologics and biotechnology and combination products in virtually all dosage forms. Ron’s career has been focused on resolution of significant quality issues and implementing quality systems that are designed to ensure compliance and rapid new product approval.